These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10319915)

  • 21. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
    Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of several new 5-lipoxygenase inhibitors in a rat Arthus pleurisy model.
    Berkenkopf JW; Weichman BM
    Eur J Pharmacol; 1991 Jan; 193(1):29-34. PubMed ID: 1646730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergen-stimulated leukotriene B4 and interleukin-8 levels in patients with asthma and allergic rhinitis-modulation by a lipid pathway inhibitor.
    Frieri M; Therattil JM; Zitt M; Bouboulis D; Wang SF; Lark G; Schaefer PA; Sansone G
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):331-6. PubMed ID: 9809497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.
    Carlson RP; O'Neill-Davis L; Calhoun W; Datko L; Musser JH; Kreft AF; Chang JY
    Agents Actions; 1989 Mar; 26(3-4):319-28. PubMed ID: 2500009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo.
    Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J
    Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of leukotriene B4 biosynthesis by disulfiram and A-64077 during carrageenan-induced pleurisy in the rat.
    Riendeau D; Guay J; Foster A; Wolfe S; Chan CC
    Gen Pharmacol; 1991; 22(2):371-4. PubMed ID: 1647348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological modulation of human platelet leukotriene C4-synthase.
    Sala A; Folco G; Henson PM; Murphy RC
    Biochem Pharmacol; 1997 Mar; 53(6):905-8. PubMed ID: 9113110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of leukotriene biosynthesis in the rat peritoneal cavity.
    Young PR; Bell RL; Lanni C; Summers JB; Brooks DW; Carter GW
    Eur J Pharmacol; 1991 Dec; 205(3):259-66. PubMed ID: 1817962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.
    Rezende BM; Athayde RM; Gonçalves WA; Resende CB; Teles de Tolêdo Bernardes P; Perez DA; Esper L; Reis AC; Rachid MA; Castor MGME; Cunha TM; Machado FS; Teixeira MM; Pinho V
    J Exp Med; 2017 Nov; 214(11):3399-3415. PubMed ID: 28947611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
    Boros V; Burghardt JS; Morgan CJ; Olson DM
    Am J Physiol; 1997 Mar; 272(3 Pt 1):L433-41. PubMed ID: 9124600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 5-lipoxygenase inhibitors on in situ LTB4 biosynthesis following calcium ionophore stimulation in the rat pleural cavity.
    Raychaudhuri A; Chertock H; Peppard J; White WD; Koeler J; DiPasquale G
    Agents Actions; 1993; 39 Spec No():C43-5. PubMed ID: 8273581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.
    Kolasa T; Gunn DE; Bhatia P; Basha A; Craig RA; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
    J Med Chem; 2000 Aug; 43(17):3322-34. PubMed ID: 10966751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of endotoxin-induced hypothermia and serum TNF-alpha levels in CD-1 mice by various pharmacological agents.
    Ochalski SJ; Hartman DA; Belfast MT; Walter TL; Glaser KB; Carlson RP
    Agents Actions; 1993; 39 Spec No():C52-4. PubMed ID: 8273585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
    Liles WC; Meier KE; Henderson WR
    J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
    Rosenthal MD; Franson RC
    J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
    Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist.
    Howell RE; Jenkins LP; Hartman DA; Gray WB; Kubrak D; Carlson RP; Kreft AF; Grimes D
    Inflamm Res; 1995 Aug; 44 Suppl 2():S170-1. PubMed ID: 8548382
    [No Abstract]   [Full Text] [Related]  

  • 40. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
    Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
    Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.